Synergistic angiogenic effect of codelivering fibroblast growth factor 2 and granulocyte-colony stimulating factor from fibrin scaffolds and bone marrow transplantation in critical limb ischemia

Tissue Engineering - Part A

Volumn 17, Issue 1-2, 2011, Pages 243-254

  Layman, Hans ^a   Rahnemai Azar, Amir A ^b   Pham, Si M ^b   Tsechpenakis, Gavriil ^c,d   Andreopoulos, Fotios M ^a,b  

^a University of Miami   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d University of Miami   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; ENHANCED RECOVERY; FIBROBLASTS; MUSCLE; PEPTIDES; STEM CELLS;

ANGIOGENESIS; ARTERIOGENESIS; BALB/C MICE; BASIC FIBROBLAST GROWTH FACTOR; BLOOD FLOW; BONE MARROW; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CAPILLARY FORMATION; CYTOKINES; FIBRIN GELS; FIBRIN MATRIX; FIBRIN SCAFFOLD; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE-COLONY STIMULATING FACTOR; GROWTH FACTOR DELIVERY; HIND LIMBS; IMMUNOHISTOCHEMISTRY; LASER DOPPLER PERFUSION IMAGING; PAINTING TECHNIQUES; PERIPHERAL ARTERY DISEASE; REPERFUSION; SMOOTH MUSCLE ACTINS; THERAPEUTIC ANGIOGENESIS;

BONE;

MUS;

FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE COLONY STIMULATING FACTOR; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CATTLE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; HINDLIMB; HUMAN; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MALE; METHODOLOGY; MOUSE; PATHOLOGY;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CATTLE; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE COLONY-STIMULATING FACTOR; HINDLIMB; HUMANS; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MALE; MICE; MICE, INBRED BALB C; TISSUE SCAFFOLDS;

EID: 78650897908     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0270     Document Type: Article

References (41)

1. Comerota, A.J. Endovascular and surgical revascularization for patients with intermittent claudication. Am J Cardiol 87, 34D, 2001.
2. Kuhlmann, M.T., Klocke, R., and Nikol, S. Therapeutic an-giogenesis for peripheral artery disease: cytokine therapy. Vasa 36, 253, 2007.
3. Belting, M., Dorrell, M.I., Sandgren, S., Aguilar, E., Ahamed, J., Dorfleutner, A., Carmeliet, P., Mueller, B.M., Friedlander, M., and Ruf, W. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 10, 502, 2004.
4. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964, 1997.
5. Rafii, S., and Lyden, D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9, 702, 2003.
6. Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Chen, D., Iwaguro, H., Inao, Y., Silver, H., and Isner, J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85, 221, 1999.
7. Majka, S.M., Jackson, K.A., Kienstra, K.A., Majesky, M.W., Goodell, M.A., and Hirschi, K.K. Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 111, 71, 2003.
8. Gounis, M.J., Spiga, M.G., Graham, R.M., Wilson, A., Hali-ko, S., Lieber, B.B., Wakhloo, A.K., and Webster, K.A. An-giogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gene Ther 12, 762, 2005.
9. Rivard, A., Silver, M., Chen, D., Kearney, M., Magner, M., Annex, B., Peters, K., and Isner, J.M. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adenovEGF. Am J Pathol 154, 355, 1999.
10. Rivard, A., Berthou-Soulie, L., Principe, N., Kearney, M., Curry, C., Branellec, D., Semenza, G.L., and Isner, J.M. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 275, 29643, 2000.
11. Jeon, O., Kang, S.W., Lim, H.W., Choi, D., Kim, D.I., Lee, S.H., Chung, J.H., and Kim, B.S. Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. Biomaterials 27, 1617, 2006.
12. Mifune, Y., Matsumoto, T., Kawamoto, A., Kuroda, R., Shoji, T., Iwasaki, H., Kwon, S.M., Miwa, M., Kurosaka, M., and Asahara, T. Local delivery of granulocyte colony stimulating factor-mobilized CD34-positive progenitor cells using bios-caffold for modality of unhealing bone fracture. Stem Cells 26, 1395, 2008.
13. Jeon, O., Song, S.J., Bhang, S.H., Choi, C.Y., Kim, M.J., and Kim, B.S. Additive effect of endothelial progenitor cell mobilization and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. J Biomed Sci 14, 323, 2007.
14. Layman, H., Sacasa, M., Murphy, A.E., Murphy, A.M., Pham, S.M., and Andreopoulos, F.M. Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model. Acta Biomater 5, 230, 2009.
15. Jain, R.K. Molecular regulation of vessel maturation. Nat Med 9, 685, 2003.
16. Layman, H., Spiga, M.G., Brooks, T., Pham, S., Webster, K.A., and Andreopoulos, F.M. The effect of the controlled release of basic fibroblast growth factor from ionic gelatin-based hydrogels on angiogenesis in a murine critical limb ischemic model. Biomaterials 28, 2646, 2007.
17. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J.M., and Asahara, T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5, 434, 1999.
18. Lederman, R.J., Mendelsohn, F.O., Anderson, R.D., Saucedo, J.F., Tenaglia, A.N., Hermiller, J.B., Hillegass, W.B., Rocha-Singh, K., Moon, T.E., Whitehouse, M.J., and Annex, B.H. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359, 2053, 2002.
19. Carmeliet, P. Mechanisms of angiogenesis and arteriogen-esis. Nat Med 6, 389, 2000.
20. Zacchigna, S., Tasciotti, E., Kusmic, C., Arsic, N., Sorace, O., Marini, C., Marzullo, P., Pardini, S., Petroni, D., Pattarini, L., Moimas, S., Giacca, M., and Sambuceti, G. In vivo imaging shows abnormal function of vascular endothelial growth factorinduced vasculature. Hum Gene Ther 18, 515, 2007.
21. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19, 1029, 2001.
22. Jeon, O., Hwang, K.C., Yoo, K.J., and Kim, B.S. Combined sustained delivery of basic fibroblast growth factor and administration of granulocyte colony-stimulating factor: syn-ergistic effect on angiogenesis in mouse ischemic limbs. J Endovasc Ther 13, 175, 2006.
23. Sica, V., Williams-Ignarro, S., de Nigris, F., D'Armiento, F.P., Lerman, L.O., Balestrieri, M.L., Maione, C., Palagiano, A., Rossiello, L., Ignarro, L.J., and Napoli, C. Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb. Cell Cycle 5, 2903, 2006.
24. Lawall, H., Bramlage, P., and Amann, B. Stem cell and progenitor cell therapy in peripheral artery disease. Thromb Haemost 103, 696, 2010.
25. Cao, L., and Mooney, D.J. Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv Drug Deliv Rev 10, 1340, 2007.
26. Powell, T.M., Paul, J.D., Hill, J.M., Thompson, M., Benjamin, M., Rodrigo, M., McCoy, J.P., Read, E.J., Khuu, H.M., Leit-man, S.F., Finkel, T., and Cannon, R.O. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25, 296, 2005.
27. Tan, Y., Li, Y., Xiao, J., Shao, H., Sing, C., Arteel, G.E., Webster, K.A., Yan, J., Yu, H., Cai, L., and Li, X. A novel CXCR4 antagonist derived from human SDF-1beta enhances angiogenesis in ischaemic mice. Cardiovasc Res 82, 513, 2009.
28. Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., and Isner, J.M. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18, 3964, 1999.
29. Schense, J.C., Bloch, J., Aebischer, P., and Hubbell, J.A. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nat Biotechnol 18, 415, 2000.
30. Li, Y., Song, Y., Zhao, L., Gaidosh, G., Laties, A.M., and Wen, R. Direct labeling and visualization of blood vessels with li-pophilic carbocyanine dye DiI. Nat Protoc 3, 1703, 2008.
31. Helisch, A., Wagner, S., Khan, N., Drinane, M., Wolfram, S., Heil, M., Ziegelhoeffer, T., Brandt, U., Pearlman, J.D., Swarts, H.M., and Schaper, W. Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler Thromb Vasc Biol 26, 520, 2006.
32. Wong, C., Inman, E., Spaethe, R., and Helgerson, S. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost 89, 573, 2003.
33. Ahmed, T.A., Dare, E.V., and Hincke, M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B 14, 199, 2008.
34. Zhang, G., and Suggs, L.J. Matricies and scaffolds for drug delivery in vascular tissue engineering. Adv Drug Deliv Rev 59, 360, 2007.
35. Rowe, S.L., Lee, S., and Stegemann, J.P. Influence of thrombin concentration on the mechanical and morphological properties of cell-seeded fibrin hydrogels. Acta Biomater 3, 59, 2007.
36. Jeon, O., Ryu, S.H., Chung, J.H., and Kim, B.S. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release 105, 249, 2005.
37. Cao, R., Eriksson, A., Kubo, H., Alitalo, K., Cao, Y., and Thyberg, J. Comparative evaluation of FGF-2-, VEGF-A-,and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 19, 664, 2004.
38. Nishimura, H., and Asahara, T. Bone marrow-derived en-dothelial progenitor cells for neovascular formation. EXS 94, 147, 2005.
39. Shi, Q., Hodara, V., Butler, S.D., Thomas, C.A., Hubbard, G.B., VandeBerg, J.L., and Wang, X.L. Differential bone marrow stem cell mobilization by G-CSF injection or arterial ligation in baboons. J Cell Mol Med 13, 1896, 2008.
40. Gazitt, Y. Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hemato-poietic growth factors. Stem Cells 18, 390, 2000.
41. Tsechpenakis, G., and Metaxas, D. CoCRF deformable model: a geometric model driven by collaborative conditional random fields. IEEE Trans Image Process 18, 2316, 2009.